Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasmsAdam S. Sperling, Koichi Takahashi, Joanne I. Hsu et al.|Blood|2022Cited by 138
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cellsRob S. Sellar, Benjamin L. Ebert, Adam S. Sperling et al.|Journal of Clinical Investigation|2022Cited by 64